Table 4.

Clinico-pathologic features demonstrating a dampened BRB effect following short-term topical administration in OSCC patients.

	OSCC2 – OSCC1
	Age	Stage	BMI
AURKA		↓	↓
BAX	↓		↓
BCL2	↓
BIRC5	↓	↓
CASP3
CASP14		↓	↓
EGFR			↓
NFKB1
PTGS1	↓
PTGS2		↓
TBXA2R	↓